Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novartis Bioventures Ltd Insider Profile
11 Followers
Novartis Bioventures Ltd, Ten Percent Owner at Eledon Pharmaceuticals, holds 4.49M shares in Eledon Pharmaceuticals (Ticker: ELDN), holds 1.87M shares in Kineta (Ticker: KA), holds 1.18M shares in AKOUOS (Ticker: AKUS). Most recently, Novartis Bioventures Ltd Sold ― shares of Eledon Pharmaceuticals on Jul 17, 2015 for an estimated value of 50.82K.
Novartis Bioventures Ltd Eledon Pharmaceuticals (ELDN)Ten Percent Owner
Eledon Pharmaceuticals (ELDN)
Ten Percent Owner
Ranked #107 out of 98,042 Corporate Insiders
Profitable Transactions
38 out of 45 Profitable Transactions
Average Return
+45.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Novartis Bioventures Ltd's holdings
Insider Roles
Roles that Novartis Bioventures Ltd holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 06, 2014 - Feb 06, 2015
Return:+103.10%
The most profitable trade made by Novartis Bioventures Ltd
Novartis Bioventures Ltd's Trading History
Eledon Pharmaceuticals
Jul 17, 2015
Ten Percent Owner
Informative Sell
50.82K
$12.13M
Kineta
―
Ten Percent Owner
―
$1.29M
Altimmune
Sep 14, 2018
Ten Percent Owner
Uninformative Buy
―
$52.41M
Spyre Therapeutics
May 14, 2018
Ten Percent Owner
Informative Sell
196.67K
$64.17M
Aileron Therapeutics
Apr 02, 2019
Ten Percent Owner
Informative Sell
236.26K
$5.70M
Aadi Bioscience
Apr 29, 2019
Ten Percent Owner
Informative Sell
722.85K
$5.79M
Galera Therapeutics
Jun 22, 2020
Former 10% Owner
Informative Sell
8.27M
$315.90K
Bicycle Therapeutics
May 30, 2019
Ten Percent Owner
Uninformative Buy
―
$39.52M
AKOUOS
Jul 02, 2020
―
Uninformative Buy
―
$15.70M
Akebia Therapeutics
Mar 27, 2014
Ten Percent Owner
Uninformative Buy
―
$246.50K
Eiger Biopharmaceuticals
Feb 06, 2014
Ten Percent Owner
Informative Buy
275.24K
$19.40M
List of latest transactions for each holding click on a transaction to see Novartis Bioventures Ltd's performance on stock
You May Also Like
Novartis Bioventures Ltd insider profile FAQ
What is the percentage of profitable transactions made by Novartis Bioventures Ltd?
The percentage of profitable transactions made by Novartis Bioventures Ltd is 84%.
What is the average return per transaction made by Novartis Bioventures Ltd?
The average return per transaction made by Novartis Bioventures Ltd is 45.10%.
What stocks does Novartis Bioventures Ltd hold?
Novartis Bioventures Ltd holds: ELDN, KA, ALT, SYRE, ALRN, AADI, GRTX, BCYC, AKUS, AKBA, EIGRQ stocks.
What was Novartis Bioventures Ltd’s latest transaction?
Novartis Bioventures Ltd latest transaction was an Informative Sell of $50.82K.
What was Novartis Bioventures Ltd's most profitable transaction?
Novartis Bioventures Ltd’s most profitable transaction was an Informative Buy of EIGRQ stock on February 6, 2014. The return on the trade was 103.10%.
What is Novartis Bioventures Ltd's role in Eledon Pharmaceuticals?
Novartis Bioventures Ltd's role in Eledon Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.